16. Intangible assets
Intangible assets
in thousand CHF |
Intangible assets with finite useful lives 1) |
Trademarks with indefinite useful lives |
Software |
Goodwill |
Total intangible assets |
Net carrying amount as at 31.12.2020 |
5,739 |
57,022 |
61,872 |
791,588 |
916,222 |
Addition |
151 |
– |
18,098 |
– |
18,250 |
Reclassification |
–9 |
– |
–61 |
– |
–70 |
Amortisation |
–1,653 |
– |
–8,293 |
– |
–9,946 |
Addition to scope of consolidation (restated) |
3,440 |
25,698 |
2,000 |
65,073 2) |
96,211 2) |
Net carrying amount as at 31.12.2021 (restated) |
7,668 |
82,720 |
73,616 |
856,662 2) |
1,020,666 2) |
Addition |
– |
– |
29,676 |
– |
29,676 |
Disposal |
–41 |
– |
– |
– |
–41 |
Amortisation |
–2,087 |
– |
–10,997 |
– |
–13,084 |
Addition to scope of consolidation |
4,910 |
– |
– |
58,600 |
63,510 |
Disposal from scope of consolidation |
–28 |
– |
–28 |
–558 |
–614 |
Net carrying amount as at 31.12.2022 |
10,422 |
82,720 |
92,267 |
914,703 |
1,100,112 |
|
|
|
|
|
|
Overview as at 31.12.2021 |
|
|
|
|
|
Cost (restated) |
17,690 |
82,720 |
119,000 |
856,662 2) |
1,076,073 2) |
Accumulated amortisation and impairment |
–10,023 |
– |
–45,384 |
– |
–55,407 |
Net carrying amount as at 31.12.2021 (restated) |
7,668 |
82,720 |
73,616 |
856,662 2) |
1,020,666 2) |
|
|
|
|
|
|
Overview as at 31.12.2022 |
|
|
|
|
|
Cost |
21,982 |
82,720 |
147,680 |
914,703 |
1,167,085 |
Accumulated amortisation and impairment |
–11,561 |
– |
–55,413 |
– |
–66,973 |
Net carrying amount as at 31.12.2022 |
10,422 |
82,720 |
92,267 |
914,703 |
1,100,112 |
1) Including trademarks, patents, licences and customer relationships
2) Figures restated (refer to note 2)
Trademarks with indefinite useful lives
This position includes trademarks that are well known nationally and internationally and actively advertised. These acquired trademarks are regarded as having indefinite useful lives for the following reasons: they were created many years ago, they do not expire, and the products sold under the trademarks have a history of strong revenue and cash flow performance. Galenica intends and has the ability to support the trademarks to maintain their values for the foreseeable future.
For impairment testing purposes the trademarks have been allocated to the cash-generating units Verfora and Spagyros in the operating segment Products & Care. The recoverable amount (higher of fair value less costs of disposal and value in use) is determined on the basis of future discounted cash flows. Cash flows beyond the three-year planning period are based on the growth rates and discount rates before tax set out below, as approved in medium-term planning by management:
Trademarks with indefinite useful lives
in thousand CHF |
2022 |
2021 |
Carrying amount |
82,720 |
82,720 |
Growth rate |
1.0% |
1.0% |
Pre-tax discount rate |
6.8% |
6.2% |
According to the results of impairment testing for 2022 and 2021 using value in use calculations, no impairment was necessary. Galenica performed a sensitivity analysis taking into account reasonable changes in the assumptions used to calculate the discounted cash flows, such as higher discount rates, lower EBITDA, lower gross margins or lower perpetual growth rates. The sensitivity analysis for 2022 and 2021 did not reveal that a reasonable possible change in assumption would lead to an impairment.
Goodwill
Goodwill
|
|
2022 |
|
2021 (Restated) |
||
in thousand CHF |
Carrying amount |
Growth rate |
Pre-tax discount rate |
Carrying amount |
Growth rate |
Pre-tax discount rate |
Products & Care |
829,156 |
1.0% |
7.0% |
768,295 1) |
1.0% |
6.5% |
Logistics & IT |
85,547 |
1.0% |
7.0% |
88,366 |
1.0% |
6.5% |
Total |
914,703 |
|
|
856,662 1) |
|
|
1) Figures restated (refer to note 2)
According to the results of impairment testing for 2022 and 2021 using value in use calculations, no impairment was necessary. Galenica performed a sensitivity analysis taking into account reasonable changes in the assumptions used to calculate the discounted cash flows, such as higher discount rates, lower EBITDA, lower gross margins or lower perpetual growth rates. The sensitivity analysis for 2022 and 2021 did not reveal that a reasonable possible change in assumption would lead to an impairment.
Accounting principles intangible assets
Intangible assets include acquired trademarks, patents, licences, customer relationships, purchased or internally developed software and other assets without physical substance. These items are measured at cost less accumulated amortisation and impairment. The cost of an intangible asset acquired in a business combination corresponds to its fair value determined at acquisition date.
Expenditure on internally developed software is capitalised when the capitalisation criteria are met and future economic benefits from use or sale of the software are expected. Software that is not yet available for use is tested for impairment annually or more frequently if there are indications of impairment.
Amortisation is charged on a straight-line basis over the estimated economic or legal useful life, whichever is shorter as follows:
|
Years |
Trademarks, patents, licences, customer relationships |
5 – 20 |
Software |
2 – 15 |
The amortisation period and the amortisation method are reviewed at least at each financial year-end.
With the exception of trademarks in the business area Products & Brands, all intangible assets are assessed as having a finite useful life. Intangible assets with indefinite useful lives are not amortised but tested for impairment annually or more frequently if there are indications of impairment. Intangible assets with finite useful lives are tested for impairment whenever there are indications that they could be impaired. Any impairment is recognised in profit or loss in depreciation and amortisation and disclosed separately as an impairment.
Goodwill is allocated to the cash-generating unit (CGU) or group of CGUs that are expected to benefit from a business combination. Management monitors goodwill at operating segment level.
Goodwill is tested for impairment annually, or more frequently if there are indications of impairment. The impairment test is based on the discounted cash flow method. The WACC is used to determine the applicable pre-tax discount rate. The recoverable amount (higher of fair value less costs of disposal and value in use) of each CGU is determined on the basis of the medium-term plans for the next three years approved by management. Cash flows beyond the three-year planning period are extrapolated using a perpetual growth rate. If the recoverable amount is lower than the carrying amount, the carrying amount is reduced to the recoverable amount by recording an impairment charge.
Any impairment on goodwill is recognised in profit or loss and disclosed separately. An impairment loss for goodwill is not reversed.